#thesicktimes — Public Fediverse posts

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

THREAT MODEL: COVID 🦠
for Apr. 2nd, 2026
by independent journalist @violetblue

- #LitCovid , "A literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus", hits 482,591 publications

- BA.3.2 (“Cicada”) spread starts picking up speed in the US

- Covid levels rising in #Canada

- Mounting evidence of the link between #LongCovid and autoimmunity

- Long COVID associated with increased risk of cardiovascular disease

- Coverage of the Long Covid forum in California from #TheSickTimes

- How Māori communities tackled the dawn of the Covid pandemic in #Aotearoa #NewZealand

...and much more.

✨THREAT MODEL is free to read -- please help keep it accessible to all by becoming a patron, even $1 a month makes a difference!✨

https://www.patreon.com/posts/covid-april-2-154573634

#ThreatModel #ThreatModelCovid #ThreatModelNewsletters #VioletBlue #COVIDnews #PublicHealth #CovidIsNotOver

THREAT MODEL: COVID 🦠
for Apr. 2nd, 2026
by independent journalist @violetblue

- #LitCovid , "A literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus", hits 482,591 publications

- BA.3.2 (“Cicada”) spread starts picking up speed in the US

- Covid levels rising in #Canada

- Mounting evidence of the link between #LongCovid and autoimmunity

- Long COVID associated with increased risk of cardiovascular disease

- Coverage of the Long Covid forum in California from #TheSickTimes

- How Māori communities tackled the dawn of the Covid pandemic in #Aotearoa #NewZealand

...and much more.

✨THREAT MODEL is free to read -- please help keep it accessible to all by becoming a patron, even $1 a month makes a difference!✨

https://www.patreon.com/posts/covid-april-2-154573634

#ThreatModel #ThreatModelCovid #ThreatModelNewsletters #VioletBlue #COVIDnews #PublicHealth #CovidIsNotOver

THREAT MODEL: COVID 🦠
for Apr. 2nd, 2026
by independent journalist @violetblue

- #LitCovid , "A literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus", hits 482,591 publications

- BA.3.2 (“Cicada”) spread starts picking up speed in the US

- Covid levels rising in #Canada

- Mounting evidence of the link between #LongCovid and autoimmunity

- Long COVID associated with increased risk of cardiovascular disease

- Coverage of the Long Covid forum in California from #TheSickTimes

- How Māori communities tackled the dawn of the Covid pandemic in #Aotearoa #NewZealand

...and much more.

✨THREAT MODEL is free to read -- please help keep it accessible to all by becoming a patron, even $1 a month makes a difference!✨

https://www.patreon.com/posts/covid-april-2-154573634

#ThreatModel #ThreatModelCovid #ThreatModelNewsletters #VioletBlue #COVIDnews #PublicHealth #CovidIsNotOver

THREAT MODEL: COVID 🦠
for Apr. 2nd, 2026
by independent journalist @violetblue

- #LitCovid , "A literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus", hits 482,591 publications

- BA.3.2 (“Cicada”) spread starts picking up speed in the US

- Covid levels rising in #Canada

- Mounting evidence of the link between #LongCovid and autoimmunity

- Long COVID associated with increased risk of cardiovascular disease

- Coverage of the Long Covid forum in California from #TheSickTimes

- How Māori communities tackled the dawn of the Covid pandemic in #Aotearoa #NewZealand

...and much more.

✨THREAT MODEL is free to read -- please help keep it accessible to all by becoming a patron, even $1 a month makes a difference!✨

https://www.patreon.com/posts/covid-april-2-154573634

#ThreatModel #ThreatModelCovid #ThreatModelNewsletters #VioletBlue #COVIDnews #PublicHealth #CovidIsNotOver

THREAT MODEL: COVID 🦠
for Apr. 2nd, 2026
by independent journalist @violetblue

- #LitCovid , "A literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus", hits 482,591 publications

- BA.3.2 (“Cicada”) spread starts picking up speed in the US

- Covid levels rising in #Canada

- Mounting evidence of the link between #LongCovid and autoimmunity

- Long COVID associated with increased risk of cardiovascular disease

- Coverage of the Long Covid forum in California from #TheSickTimes

- How Māori communities tackled the dawn of the Covid pandemic in #Aotearoa #NewZealand

...and much more.

✨THREAT MODEL is free to read -- please help keep it accessible to all by becoming a patron, even $1 a month makes a difference!✨

https://www.patreon.com/posts/covid-april-2-154573634

#ThreatModel #ThreatModelCovid #ThreatModelNewsletters #VioletBlue #COVIDnews #PublicHealth #CovidIsNotOver

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· SARS-CoV-2 reinfections significantly increase the risk of #LongCOVID in children, a new National Institutes of Health (NIH) RECOVER study found
· A large cohort study found further evidence that people with #HIV have a significantly increased risk of Long COVID following SARS-CoV-2 infection
· An in-depth whole genome sequencing study called Sequence #MECFS and Long COVID is seeking to raise £20 million ($23.6 million USD) in funding

https://thesicktimes.org/2026/02/24/research-updates-february-24/

#ResearchUpdates #TheSickTimes

· SARS-CoV-2 reinfections significantly increase the risk of #LongCOVID in children, a new National Institutes of Health (NIH) RECOVER study found
· A large cohort study found further evidence that people with #HIV have a significantly increased risk of Long COVID following SARS-CoV-2 infection
· An in-depth whole genome sequencing study called Sequence #MECFS and Long COVID is seeking to raise £20 million ($23.6 million USD) in funding

https://thesicktimes.org/2026/02/24/research-updates-february-24/

#ResearchUpdates #TheSickTimes

· SARS-CoV-2 reinfections significantly increase the risk of #LongCOVID in children, a new National Institutes of Health (NIH) RECOVER study found
· A large cohort study found further evidence that people with #HIV have a significantly increased risk of Long COVID following SARS-CoV-2 infection
· An in-depth whole genome sequencing study called Sequence #MECFS and Long COVID is seeking to raise £20 million ($23.6 million USD) in funding

https://thesicktimes.org/2026/02/24/research-updates-february-24/

#ResearchUpdates #TheSickTimes

· SARS-CoV-2 reinfections significantly increase the risk of #LongCOVID in children, a new National Institutes of Health (NIH) RECOVER study found
· A large cohort study found further evidence that people with #HIV have a significantly increased risk of Long COVID following SARS-CoV-2 infection
· An in-depth whole genome sequencing study called Sequence #MECFS and Long COVID is seeking to raise £20 million ($23.6 million USD) in funding

https://thesicktimes.org/2026/02/24/research-updates-february-24/

#ResearchUpdates #TheSickTimes

· SARS-CoV-2 reinfections significantly increase the risk of #LongCOVID in children, a new National Institutes of Health (NIH) RECOVER study found
· A large cohort study found further evidence that people with #HIV have a significantly increased risk of Long COVID following SARS-CoV-2 infection
· An in-depth whole genome sequencing study called Sequence #MECFS and Long COVID is seeking to raise £20 million ($23.6 million USD) in funding

https://thesicktimes.org/2026/02/24/research-updates-february-24/

#ResearchUpdates #TheSickTimes

New issue of #TheSickTimes includes a study that found no evidence that wearable alerts improve pacing.

https://thesicktimes.org/2026/02/17/research-updates-february-17/

Not super surprised by this.

The alerts themselves can trigger emotional and sensory exertion.

The data they're generally tracking includes just one type of stressor (physical) - I have yet to find a wearable that can (for example) track emotional overload via voice characteristics; track cognitive load via things like "time spent on computer"; track sensory stimulation via light and sound levels and rate of change.

The proportion of time spent resting and type of rest is a critical factor that is also generally not tracked: vertical vs horizontal vs reclined; physical vs cognitive vs sensory and emotional; degree of stressors and type of stimuli present.

As long as a trial fails to track rest as well as the different types of exertion, impact will be buried in the noise.

@longcovid @mecfs
#LongCovid #MECFS #StopRestPace #PASC

New issue of #TheSickTimes includes a study that found no evidence that wearable alerts improve pacing.

https://thesicktimes.org/2026/02/17/research-updates-february-17/

Not super surprised by this.

The alerts themselves can trigger emotional and sensory exertion.

The data they're generally tracking includes just one type of stressor (physical) - I have yet to find a wearable that can (for example) track emotional overload via voice characteristics; track cognitive load via things like "time spent on computer"; track sensory stimulation via light and sound levels and rate of change.

The proportion of time spent resting and type of rest is a critical factor that is also generally not tracked: vertical vs horizontal vs reclined; physical vs cognitive vs sensory and emotional; degree of stressors and type of stimuli present.

As long as a trial fails to track rest as well as the different types of exertion, impact will be buried in the noise.

@longcovid @mecfs
#LongCovid #MECFS #StopRestPace #PASC

New issue of #TheSickTimes includes a study that found no evidence that wearable alerts improve pacing.

https://thesicktimes.org/2026/02/17/research-updates-february-17/

Not super surprised by this.

The alerts themselves can trigger emotional and sensory exertion.

The data they're generally tracking includes just one type of stressor (physical) - I have yet to find a wearable that can (for example) track emotional overload via voice characteristics; track cognitive load via things like "time spent on computer"; track sensory stimulation via light and sound levels and rate of change.

The proportion of time spent resting and type of rest is a critical factor that is also generally not tracked: vertical vs horizontal vs reclined; physical vs cognitive vs sensory and emotional; degree of stressors and type of stimuli present.

As long as a trial fails to track rest as well as the different types of exertion, impact will be buried in the noise.

@longcovid @mecfs
#LongCovid #MECFS #StopRestPace #PASC

New issue of #TheSickTimes includes a study that found no evidence that wearable alerts improve pacing.

https://thesicktimes.org/2026/02/17/research-updates-february-17/

Not super surprised by this.

The alerts themselves can trigger emotional and sensory exertion.

The data they're generally tracking includes just one type of stressor (physical) - I have yet to find a wearable that can (for example) track emotional overload via voice characteristics; track cognitive load via things like "time spent on computer"; track sensory stimulation via light and sound levels and rate of change.

The proportion of time spent resting and type of rest is a critical factor that is also generally not tracked: vertical vs horizontal vs reclined; physical vs cognitive vs sensory and emotional; degree of stressors and type of stimuli present.

As long as a trial fails to track rest as well as the different types of exertion, impact will be buried in the noise.

@longcovid @mecfs
#LongCovid #MECFS #StopRestPace #PASC

New issue of #TheSickTimes includes a study that found no evidence that wearable alerts improve pacing.

https://thesicktimes.org/2026/02/17/research-updates-february-17/

Not super surprised by this.

The alerts themselves can trigger emotional and sensory exertion.

The data they're generally tracking includes just one type of stressor (physical) - I have yet to find a wearable that can (for example) track emotional overload via voice characteristics; track cognitive load via things like "time spent on computer"; track sensory stimulation via light and sound levels and rate of change.

The proportion of time spent resting and type of rest is a critical factor that is also generally not tracked: vertical vs horizontal vs reclined; physical vs cognitive vs sensory and emotional; degree of stressors and type of stimuli present.

As long as a trial fails to track rest as well as the different types of exertion, impact will be buried in the noise.

@longcovid @mecfs
#LongCovid #MECFS #StopRestPace #PASC

· A large, electronic health records study published in JAMA Internal Medicine estimated that over 100,000 Americans died each year between 2022 and 2024 from #COVID19
· A new study published in Molecular & Cellular Proteomics found further evidence of abnormalities in post-exertional malaise #PEM
· A small phase two clinical trial is testing #Ketamine for #LongCOVID fatigue and cognitive function

https://thesicktimes.org/2026/01/13/research-updates-january-13/

#ResearchUpdates #TheSickTimes

· A large, electronic health records study published in JAMA Internal Medicine estimated that over 100,000 Americans died each year between 2022 and 2024 from #COVID19
· A new study published in Molecular & Cellular Proteomics found further evidence of abnormalities in post-exertional malaise #PEM
· A small phase two clinical trial is testing #Ketamine for #LongCOVID fatigue and cognitive function

https://thesicktimes.org/2026/01/13/research-updates-january-13/

#ResearchUpdates #TheSickTimes

· A large, electronic health records study published in JAMA Internal Medicine estimated that over 100,000 Americans died each year between 2022 and 2024 from #COVID19
· A new study published in Molecular & Cellular Proteomics found further evidence of abnormalities in post-exertional malaise #PEM
· A small phase two clinical trial is testing #Ketamine for #LongCOVID fatigue and cognitive function

https://thesicktimes.org/2026/01/13/research-updates-january-13/

#ResearchUpdates #TheSickTimes

· A large, electronic health records study published in JAMA Internal Medicine estimated that over 100,000 Americans died each year between 2022 and 2024 from #COVID19
· A new study published in Molecular & Cellular Proteomics found further evidence of abnormalities in post-exertional malaise #PEM
· A small phase two clinical trial is testing #Ketamine for #LongCOVID fatigue and cognitive function

https://thesicktimes.org/2026/01/13/research-updates-january-13/

#ResearchUpdates #TheSickTimes

· A large, electronic health records study published in JAMA Internal Medicine estimated that over 100,000 Americans died each year between 2022 and 2024 from #COVID19
· A new study published in Molecular & Cellular Proteomics found further evidence of abnormalities in post-exertional malaise #PEM
· A small phase two clinical trial is testing #Ketamine for #LongCOVID fatigue and cognitive function

https://thesicktimes.org/2026/01/13/research-updates-january-13/

#ResearchUpdates #TheSickTimes